Enhancing the antibiotic antibacterial effect by sub lethal tellurite concentrations: Tellurite and cefotaxime act synergistically in escherichia coli

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Molina Quiroz, Roberto C ^a   Muñoz Villagrán, Claudia M ^a   de la Torre, Erick ^b   Tantaleán, Juan C ^b   Vásquez, Claudio C ^a   Pérez Donoso, José M ^a,c  

^a UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^b Universidad Nacional San Luis Gonzaga   (Peru)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; GENTAMICIN; TELLURITE; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; TELLURIUM; TELLUROUS ACID;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ESCHERICHIA COLI; HUMAN; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; SPECIES DIFFERENTIATION; STAPHYLOCOCCUS AUREUS; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION;

AMPICILLIN; ANTI-BACTERIAL AGENTS; CEFOTAXIME; CHLORAMPHENICOL; DRUG SYNERGISM; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; TELLURIUM; TETRACYCLINE;

EID: 84859968962     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035452     Document Type: Article

References (32)

1. Dantas G, Sommer M, Oluwasegun R, Church GM, (2008) Bacteria subsisting on antibiotics. Science 320: 100-103.
2. Walsh C, (2003) Where will new antibiotics come from? Nat Rev Microbiol 1: 65-70.
3. Banin E, Lozinski A, Brady KM, Berenshtein E, Butterfield PW, et al. (2008) The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc Natl Acad Sci USA 105: 16761-16766.
4. Hemaiswarya S, Doble M, (2010) Synergistic interaction of phenylpropanoids with antibiotics against bacteria. J Med Microbiol 59: 1469-1476.
5. Lu TK, Collins JJ, (2009) Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci USA 106: 4629-4634.
6. Kohanski M, Dwyer D, Hayete B, Lawrence C, Collins J, (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797-810.
7. Fleming A, (1932) On the specific antibacterial properties of penicillin and potassium tellurite. Incorporating a method of demonstrating some bacterial antagonisms. J Pathol Bacteriol 35: 831-842.
8. Chapman P, Siddons C, Zadik P, Jewes L, (1991) An improved selective medium for the isolation of Escherichia coli O157. J Med Microbiol 35: 107-110.
9. Pérez J, Calderón I, Arenas F, Fuentes D, Pradenas, et al. (2007) Bacterial toxicity of potassium tellurite: unveiling an ancient enigma. PLoS ONE 2: e211.
10. Calderón I, Elías A, Fuentes E, Pradenas G, Castro M, et al. (2009) Tellurite-mediated disabling of [4Fe-4S] clusters of Escherichia coli dehydratases. Microbiology 155: 1840-1846.
11. Castro M, Molina R, Díaz WA, Pradenas GA, Vásquez CC, (2009) Expression of Aeromonas caviae ST pyruvate dehydrogenase complex components mediate tellurite resistance in Escherichia coli. Biochem Biophys Res Commun 380: 148-152.
12. Turner RJ, Aharonowitz Y, Weiner J, Taylor DE, (2001) Glutathione is a target in tellurite toxicity and is protected by tellurite resistance determinants in Escherichia coli. Can J Microbiol 47: 33-40.
13. Pérez J, Arenas F, Pradenas G, Sandoval J, Vásquez CC, (2008) Escherichia coli YqhD exhibits aldehyde reductase activity and protects from the harmful effect of lipid peroxidation-derived aldehydes. J Biol Chem 283: 7346-7353.
14. Chasteen TG, Fuentes DE, Tantaleán JC, Vásquez CC, (2009) Tellurite: history, oxidative stress, and molecular mechanisms of resistance. FEMS Microbiol Rev 33: 820-832.
15. Sandoval J, Leveque P, Gallez B, Vásquez CC, Buc-Calderon P, (2010) Tellurite-induced oxidative stress leads to cell death of murine hepatocarcinoma cells. Biometals 23: 623-632.
16. Livermore DM, Woodford N, (2006) The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 14: 413-420.
17. Lepercq J, Treluyer J, Auger C, Raymond J, Rey E, et al. (2009) Evaluation of cefotaxime and desacetylcefotaxime concentrations in cord blood after intrapartum prophylaxis with cefotaxime. Antimicrob Agents Chemother 53: 2342-2345.
18. Schroeder H, (1967) Effects of selenate, selenite and tellurite on the growth and early survival of mice and rats. J Nutr 92: 334-338.
19. Wagner M, Toews AD, Morell P, (1995) Tellurite specifically affects squalene epoxidase: investigations examining the mechanism of tellurium-induced neuropathy. J Neurochem 64: 2169-2176.
20. Nix D, Schentag J, (1995) Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics. Diagn Microbiol Infect Dis 22: 71-76.
21. Ford CW, Zurenko GE, Barbachyn MR, (2001) The discovery of linezolid, the first oxazolidinone antibacterial agent. Curr Drug Targets Infect Disord 1: 181-199.
22. LaPlante K, Rybak M, (2004) Daptomycin- a novel antibiotic against Gram-positive pathogens. Expert Opin Pharmacother 5: 2321-2331.
23. Ison CA, Hussey J, Sankar KN, Evans J, Alexander S, (2011) Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 16: pii = 19833 Available:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19833.
24. Kumarasamy K, Toleman M, Walsh T, Bagaria J, Butt F, et al. (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10: 597-602.
25. Asakura T, Shibutani Y, Reilly MP, DeMeio RH, (1984) Antisickling effect of tellurite: a potent membrane-acting agent in vitro. Blood 64: 305-307.
26. Guillamet E, Creus A, Farina M, Sabbioni E, Fortaner S, et al. (2008) DNA-damage induction by eight metal compounds in TK6 human lymphoblastoid cells: results obtained with the alkaline Comet assay. Mutat Res 654: 22-28.
27. Schroeder HA, Mitchener M, (1972) Selenium and tellurium in mice. Effects on growth, survival, and tumors. Arch Environ Health 24: 66-71.
28. Schroeder HA, Mitchener M, (1971) Selenium and tellurium in rats: effect on growth, survival and tumors. J Nutr 101: 1531-1540.
29. Kohanski M, Dwyer D, Wierzbowski J, Cottarel G, Collins J, (2008) Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135: 679-690.
30. Horii T, Mase K, Suzuki Y, Kimura T, Ohta M, et al. (2002) Antibacterial activities of beta-lactamase inhibitors associated with morphological changes of cell wall in Helicobacter pylori. Helicobacter 7: 39-45.
31. Nicola G, Tomberg J, Pratt R, Nicholas R, Davies C, (2010) Crystal structures of covalent complexes of beta-lactam antibiotics with Escherichia coli penicillin-binding protein 5: towards an understanding of antibiotic specificity. Biochemistry 49: 8094-8104.
32. Kohanski MA, DePristo MA, Collins JJ, (2010) Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 37: 311-320.